Altay Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
733 Industrial Rd, San Carlos, Californi...Website
www.altaytherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Altay Therapeutics
Altay Therapeutics is focused on developing innovative therapies for serious, underserved diseases, particularly through the inhibition of transcription factors. Their pipeline includes the first oral small molecule inhibitor of DUX4 for facioscapulohumeral muscular dystrophy (FSHD) and a promising STAT3 inhibitor targeting cancer and chronic inflammatory diseases. The company aims to provide differentiated therapeutic options to patients with limited treatment choices. With a team of experienced professionals, Altay is committed to advancing drug discovery and development in precision biology.Explore more
Altay Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Altay Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Altay Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Altay Therapeutics launches new products
Click to see if Altay Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Altay Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Altay Therapeutics has new funding data
Check out if Altay Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Altay Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Altay Therapeutics
Recommended Actions
Find VP level buyers at Altay Therapeutics
Find 2 more new buyers
Compare Similar Companies to Altay Therapeutics
Compare insights from companies similar to Altay Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Altay Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Altay Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Altay Therapeutics.
Altay Therapeutics financials insights
Gather financial insights about Altay Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$3M
Altay Therapeutics Tech Stack
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment
Funding
Funding
Altay Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Altay Therapeutics
Sign Up For FreeTo access detailed company insights
Altay Therapeutics is focused on developing innovative therapies for serious, underserved diseases, particularly through the inhibition of transcription factors. Their pipeline includes the first oral small molecule inhibitor of DUX4 for facioscapulohumeral muscular dystrophy (FSHD) and a promising STAT3 inhibitor targeting cancer and chronic infla... Read More
